Official Journal of the Italian Society of Orthopaedics and Traumatology
Table 4 Further details of applied treatment
From: Ilizarov bone transport and treatment of critical-sized tibial bone defects: a narrative review
Author/s | Bone defect | Mean latency period (range) (days) | Type of Ilizarov treatment (n, Â %) | |||
|---|---|---|---|---|---|---|
Incidence (%) | Mean size (range) (cm) | Bifocal | Trifocal | Bifocal or trifocal (nr) | ||
Madhusudhan et al. | 100 | 4 (2–11) | nr (5–7) | 22 (100) | 0 (0) | 0 (0) |
Pirwani et al. | 100 | 4.5 (2–8) | nr | 16 (100) | 0 (0) | 0 (0) |
Bumbasirevic et al. | 100 | 6.9 (4–11) | 7 | 30 (100) | 0 (0) | 0 (0) |
Megas et al. | 100 | 5 (2–12) | nr (3–5) | 6 (66.6) | 0 (0) | 3 (33.3) |
Lin et al. | 100 | 8 (4–12) | 7 | 8 (50) | 8 (50) | 0 (0) |
Babar et al. | 100 | 5.8 (nr) | 7 | 17 (100) | 0 (0) | 0 (0) |
Feng et al. | 100 | 6.6 (3–12) | 7 | 21 (100) | 0 (0) | 0 (0) |
Krappinger et al. | 100 | 6.6 (3–14.7) | nr (10–14) | 15 (100) | 0 (0) | 0 (0) |
Selim | 100 | 9 (6–12) | 7 | 0 (0) | 10 (100) | 0 (0) |
Shadid et al. | nr | nr | nr | 0 (0) | 0 (0) | 12 (100) |
Spiegl et al. | 100 | 5.3 (3–13) | 7 | 25 (100) | 0 (0) | 0 (0) |
Xu et al. | 100 | 6.4 (3–12) | 7 | 0 (0) | 0 (0) | 30 (100) |
Yin et al. | 100 | 6.27 (3–13) | nr (7–10) | 66 (100) | 0 (0) | 0 (0) |
Morsy | 100 | 4.6 (4–7) | nr (7–10) | 12 (100) | 0 (0) | 0 (0) |
Marais et al. | 100 | 7 (5–8) | 7 | 7 (100) | 0 (0) | 0 (0) |
Azzam et al. | 100 | 7.4 (3.–12) | 7 | 30 (100) | 0 (0) | 0 (0) |
Bernstein et al. | 100 | 5.9 (1.6–13) | nr | 30 (100) | 0 (0) | 0 (0) |
Khan et al. | 100 | 3.2 (2–5) | nr | 8 (33.3) | 0 (0) | 16 (66.6) |
Peng et al. | 100 | 9.2 (6–15) | 10 (nr) | 58 (100) | 0 (0) | 0 (0) |
Wani et al. | 100 | 5.1 (3–8) | 7 | 18 (75) | 0 (0) | 8 (25) |
Aboumira et al. | 100 | 6.5 (3–17) | nr (12–14) | 16 (64) | 9 (36) | 0 (0) |
Aktuglu et al. | 100 | 7.01 (5–18) | nr (5–7) | 24 (100) | 0 (0) | 0 (0) |
Fürmetz et al. | 100 | 9 (3.1–13.4) | 7 | 8 (100) | 0 (0) | 0 (0) |
Rohilla et al. | 100 | 7.27 (6–12) | 7 | 35 (100) | 0 (0) | 0 (0) |
Tetsworth et al. | 100 | 7 (3–10) | nr | 21 (100) | 0 (0) | 0 (0) |
Yilihamu et al. | 100 | nr (> 3) | 10 | 14 (100) | 0 (0) | 0 (0) |
Zhang et al. | 100 | 10.9 (6–20) | nr (7–10) | 0 (0) | 16 (100) | 0 (0) |